购物车
- 全部删除
- 您的购物车当前为空
BMS-303141是高效性和可渗透细胞的 ACL 抑制剂(IC50:0.13 μM)。
为众多的药物研发团队赋能,
让新药发现更简单!
BMS-303141是高效性和可渗透细胞的 ACL 抑制剂(IC50:0.13 μM)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 229 | 现货 | |
2 mg | ¥ 319 | 现货 | |
5 mg | ¥ 538 | 现货 | |
10 mg | ¥ 866 | 现货 | |
25 mg | ¥ 1,720 | 现货 | |
50 mg | ¥ 2,570 | 现货 | |
100 mg | ¥ 3,770 | 现货 | |
500 mg | ¥ 7,930 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 593 | 现货 |
产品描述 | BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL). |
靶点活性 | ACL:0.13 μM |
体外活性 | BMS-303141 shows inhibition of total lipid syntheses with an IC50 of 8 μM in HepG2 cells. BMS-303141 shows no cytotoxicity up to 50 lM under a cell-based Alamar Blue cytotoxicity assay, indicating the observed inhibition of lipid synthesis is not a result of compound-induced cytotoxicity[1]. |
体内活性 | Chronic oral dosing of BMS-303141 in high-fat fed mice lowers approximate 20-30% plasma cholesterol and triglycerides, as well as 30-50% fasting plasma glucose. Chronic treatment with BMS-303141 shows a gradual inhibition of weight gain along with a reduction in adiposity without apparent changes in food intake. BMS-303141 exhibits an oral bioavailability of 55% while a relatively short half-life of 2.1 h[1]. |
别名 | BMS 303141 |
分子量 | 424.3 |
分子式 | C19H15Cl2NO4S |
CAS No. | 943962-47-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (129.63 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.